Exchange: NYSEArca·Updated 10:19 AM EDT
News
all
press releases
Why Did SRPT Stock Rise 6% In Pre-Market Today?
The company announced positive three-year topline results from its EMBARK study evaluating ELEVIDYS, a gene therapy for ambulatory patients with DMD.
Stocktwits
Berenberg initiates coverage of these two mid-cap U.K. names
Investing.com - M&C Saatchi’s (LON:SAA) non-advertising business is to lead growth at the company until 2027, according to analysts at Berenberg.
investing.com

Advertisement|Remove ads.